Occasionally other B-cell-derived neoplasms (B-cell lymphomas including large B-cell lymphomas with plasma cell differentiation (for example, plasmablastic lymphoma) and B-lymphoblastic leukemia/lymphoma) will be treated with an anti-CD38 therapy. The gene discussed is CD38; the disease is B-cell non-Hodgkin lymphoma.